1,25-dihydroxyvitamin D3 ameliorates high-altitude hypoxic injury via modulation of short-chain fatty acids to exert a coordinated anti-inflammatory effect
Physiological Research · 31.10.2026 · 881
DOI: 10.33549/physiolres.935858 ↗Kurz gefasst
Fachartikel in der Zeitschrift Physiological Research, online erschienen am 31.10.2026. Verfasst von Y Wang und 10 weiteren Autor:innen. Die Arbeit nennt 32 Literaturangaben.
Abstract (Originalsprache)
High-altitude hypoxic injury remains a major health threat with limited prophylactic options. This study evaluated the protective effects of 1,25-dihydroxyvitamin D3 (1,25-(OH)2D3) against acute high-altitude sickness using parallel human and animal investigations. In the clinical trial, 48 volunteers ascending to 4,200 m received either weight‑stratified 1,25-(OH)2D3 (0.102‑0.135 μg/kg/day, n=23) or placebo (n=25) for 5 days. In the animal study, 40 SD rats were exposed to 6,000 m (hypobaric hypoxia) for 48 h with or without 1,25-(OH)2D3 pretreatment. Results showed that 1,25-(OH)2D3 significantly reduced Lake Louise scores, alleviated headache, improved oxygen saturation and haemodynamics, suppressed serum pro‑inflammatory cytokines (IL‑6, IL‑1β) and inflammatory cell counts, and attenuated multi‑organ (lung, liver, kidney) hypoxic injury. In rats, 1,25-(OH)2D3 also restored Th1/Th2 immune balance, reduced oxidative stress, and down‑regulated four short‑chain fatty acids ((R)‑3‑hydroxyisobutyric acid, (S)‑2‑hydroxybutyric acid, 2‑hydroxybutyric acid, β‑hydroxyisobutyric acid) involved in butyrate metabolism. No toxic effects were observed in normoxic controls. Collectively, 1,25-(OH)2D3 effectively prevents high‑altitude hypoxic injury by suppressing inflammation, restoring immune homeostasis, and modulating short‑chain fatty acid metabolism. Our findings support 1,25-(OH)2D3 as a safe and promising prophylactic agent against high‑altitude sickness.
Zitieren
APA
Wang, Y., Li, G., Hou, N., Jimei, C., Li, Q., Dai, C., Liu, M., Su, H., Zhao, F., Li, Y., & Pu, X. (2026). 1,25-dihydroxyvitamin D3 ameliorates high-altitude hypoxic injury via modulation of short-chain fatty acids to exert a coordinated anti-inflammatory effect. Physiological Research, 881. https://doi.org/10.33549/physiolres.935858
Vancouver
Wang Y, Li G, Hou N, Jimei C, Li Q, Dai C, et al. 1,25-dihydroxyvitamin D3 ameliorates high-altitude hypoxic injury via modulation of short-chain fatty acids to exert a coordinated anti-inflammatory effect. Physiological Research. 2026:881. doi:10.33549/physiolres.935858
BibTeX
@article{Wang2026,
author = {Wang, Y and Li, G and Hou, N and Jimei, C and Li, Q and Dai, C and Liu, M and Su, H and Zhao, F and Li, Y and Pu, X},
title = {1,25-dihydroxyvitamin D3 ameliorates high-altitude hypoxic injury via modulation of short-chain fatty acids to exert a coordinated anti-inflammatory effect},
journal = {Physiological Research},
year = {2026},
pages = {881},
doi = {10.33549/physiolres.935858}
}
EUVIMED